SCHEMBL27645196

SCHEMBL27645196

Clc1cc(CC2CCN(c3cccc4scnc34)CC2)cc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.41
HTR1A P08908 5/20 0.41
HTR2A P28223 5/20 0.41
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 3/20 0.40
GRM2 Q14416 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
CCR3 P51677 1/20 0.35
MAPT P10636 3/20 0.35
HTT P42858 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 1/20 0.35
STAT3 P40763 1/20 0.35
DRD3 P35462 1/20 0.34
TSHR P16473 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27762834 0.83 DRD2 (0.34) DRD2HTR1AHTR2ASLC6A2SLC6A4
SCHEMBL27645184 0.82 DRD2 (0.48) DRD2HTR1AHTR2AMAPTDRD3
SCHEMBL2092799 0.81 MALT1 (0.34) DRD2GRM2IRAK4CCR3MAPT
SCHEMBL2092802 0.81 MALT1 (0.34) DRD2HTR1AHTR2AGRM2CCR3
SCHEMBL27645199 0.80 HRH3 (0.41) DRD2HTR1AHTR2ASLC6A2SLC6A4
SCHEMBL27666219 0.78 HTR1A (0.38) DRD2HTR1AHTR2AMAPTHTT
SCHEMBL27665965 0.74 HTR1A (0.40) DRD2HTR1AHTR2AGRM2
SCHEMBL27666166 0.73 HTR1A (0.43) DRD2HTR1AHTR2ACCR3MAPT
SCHEMBL28758338 0.72 HTR1A (0.43) DRD2HTR1AHTR2ACCR3
SCHEMBL22668657 0.72 HTR2A (0.48) DRD2HTR1AHTR2ASLC6A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed